<DOC>
	<DOCNO>NCT02581592</DOCNO>
	<brief_summary>This multiple-center , nonrandomized , open label , parallel group , single dose study conduct male female subject normal hepatic function moderate ( Child-Pugh Class B ) hepatic impairment evaluate effect hepatic impairment pharmacokinetics ( PK ) TD-4208 .</brief_summary>
	<brief_title>Pharmacokinetics TD-4208 Patients With Moderate Hepatic Impairment</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>For hepatic impairment group : Subject moderate hepatic impairment ( Child Pugh B ) For normal hepatic function group : Subject good health Women pregnant , lactating , breastfeeding , plan become pregnant study . Subject receive investigational drug ( medical device ) within 30 day Subject , reason , deem investigator inappropriate study ; condition would confound interfere evaluation safety , tolerability , PK investigational drug ; unable comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Hepatic Impairment</keyword>
	<keyword>Hepatitis</keyword>
	<keyword>Liver Cirrhosis</keyword>
</DOC>